RxDoctor Payments Data

Brian Lewis, MD

Family Medicine · Stockbridge, GANPI 1629307277

Payments from drug & device makers

$226in general payments, 2019–2025

Across 9 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$111
  • GSK$26
  • Novartis$16
  • Shire North American Group Inc$16
  • Pfizer$15
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$14
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$21394%
  • Education$146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$226 in reported general payments places this provider in the 35th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$65,816
Medicare patients
211
Services billed
4,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$60,719
OzempicSemaglutide55$58,174
JardianceEmpagliflozin34$43,566
XareltoRivaroxaban39$41,234
TrulicityDulaglutide27$39,117
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$26,715
MounjaroTirzepatide20$25,032
JanuviaSitagliptin Phosphate33$23,173
TradjentaLinagliptin17$16,538
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$14,469
FarxigaDapagliflozin Propanediol15$13,845
NamzaricMemantine Hcl/Donepezil Hcl18$7,007
Novolog FlexpenInsulin Aspart16$6,555
Breo ElliptaFluticasone/Vilanterol12$5,449
SynthroidLevothyroxine Sodium49$4,848

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$60,71970 claims
GSKTrelegy Ellipta, Breo Ellipta$26$32,16338 claims
MerckJanuvia$13$23,17333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Stockbridge

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →